These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16506351)

  • 41. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza.
    Uyeki TM
    Pediatr Infect Dis J; 2003 Feb; 22(2):164-77. PubMed ID: 12586981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
    Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
    Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neuraminidase inhibitor].
    Kaji M
    Nihon Rinsho; 2000 Nov; 58(11):2293-8. PubMed ID: 11225320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives.
    Bassetti M; Castaldo N; Carnelutti A
    Expert Opin Pharmacother; 2019 Oct; 20(14):1711-1718. PubMed ID: 31169040
    [No Abstract]   [Full Text] [Related]  

  • 45. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
    Nitsch-Osuch A; Brydak LB; Wardyn AK
    Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of the clinical effectiveness of three neuraminidase inhibitors for Japanese pediatric patients with influenza in the 2013/2014 season].
    Hishiki H; Ishiwada N; Naito S; Nagasawa K; Someya T; Inoue N; Haraki M; Kurosaki T; Kameoka Y; Suzuki K
    Jpn J Antibiot; 2015 Dec; 68(6):337-43. PubMed ID: 27004397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuraminidase inhibitor resistance in influenza viruses.
    Reece PA
    J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
    Sauerbrei A; Haertl A; Brandstaedt A; Schmidtke M; Wutzler P
    Med Microbiol Immunol; 2006 Jun; 195(2):65-71. PubMed ID: 16059699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of antivirals in the control of influenza.
    Monto AS
    Vaccine; 2003 May; 21(16):1796-800. PubMed ID: 12686097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antivirals for influenza: what is their role in the older patient?
    Dumyati G; Falsey AR
    Drugs Aging; 2002; 19(10):777-86. PubMed ID: 12390054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of influenza with antiviral drugs.
    Stiver G
    CMAJ; 2003 Jan; 168(1):49-56. PubMed ID: 12515786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
    Hurt AC; Selleck P; Komadina N; Shaw R; Brown L; Barr IG
    Antiviral Res; 2007 Mar; 73(3):228-31. PubMed ID: 17112602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two neuraminidase inhibitors for treatment of influenza.
    Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051
    [No Abstract]   [Full Text] [Related]  

  • 55. Antiviral drugs for prophylaxis and treatment of influenza.
    Med Lett Drugs Ther; 2004 Oct; 46(1194):85-7. PubMed ID: 15520621
    [No Abstract]   [Full Text] [Related]  

  • 56. Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
    McKimm-Breschkin JL; Fry AM
    Antiviral Res; 2016 May; 129():21-38. PubMed ID: 26872862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influenza: evolving strategies in treatment and prevention.
    Lynch JP; Walsh EE
    Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
    Cooper NJ; Sutton AJ; Abrams KR; Wailoo A; Turner D; Nicholson KG
    BMJ; 2003 Jun; 326(7401):1235. PubMed ID: 12791735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylaxis and treatment of influenza virus infection.
    Kandel R; Hartshorn KL
    BioDrugs; 2001; 15(5):303-23. PubMed ID: 11437694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
    Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.